» Articles » PMID: 36164339

The Mechanism of Colon Tissue Damage Mediated by HIF-1α/NF-κB/STAT1 in High-altitude Environment

Overview
Journal Front Physiol
Date 2022 Sep 27
PMID 36164339
Authors
Affiliations
Soon will be listed here.
Abstract

The high-altitude environment damages the intestinal mucosal barrier, leading to a high incidence of intestinal diseases and seriously affects the working ability of people at high altitude. However, how high altitude induces intestinal mucosal barrier injury has not been well defined. The purpose of this study was to investigate the mechanism of colonic tissue injury induced by the influence of the high-altitude environment on the colonic microenvironment. Forty-eight SPF C57BL/6J mice were randomly divided into four groups: the control group and three other that were high-altitude exposure groups (Yushu, Qinghai; elevation: 4,010 m; 12 h, 24 h, 48 h). First, HE staining was used to observe the effect of the high-altitude environment on colon histomorphology of mice. The protein expression levels of claudin-1, occludin, and ZO-1 were analyzed by molecular biological methods. We found that altitude caused inflammatory damage to colon tissue. Intestinal hypoxia was measured with the hypoxic probe pimonidazole (PMDZ). Interestingly, we observed a decrease in the concentration of oxygen in the microenvironment in the colonic lumen. We sought to explore the mechanism of colonic mucosal barrier damage at different times when entering high altitude. The expression levels of hypoxia-inducible factors: HIF-1α, STAT1, and NF-κB and of inflammatory factors: IFN-γ, TNF-α, and IL-6 were significantly increased. This work highlights that the high-altitude environment leads to a reduction in the concentration of oxygen in the microenvironment of the colonic lumen, which disrupts the colonic mucosal barrier and ultimately induces and exacerbates intestinal injury.

Citing Articles

JBLC-141 alleviates hypobaric hypoxia-induced intestinal barrier damage by attenuating inflammatory responses and oxidative stress.

Li X, Shang J, Wang X, Ma H, Ren L, Zhang L Front Microbiol. 2025; 15:1501999.

PMID: 39741588 PMC: 11685222. DOI: 10.3389/fmicb.2024.1501999.


Novel mechanisms of intestinal flora regulation in high-altitude hypoxia.

Yan F, Yuan W, Wu S, Yang Y, Cui D Heliyon. 2024; 10(20):e38220.

PMID: 39498080 PMC: 11534185. DOI: 10.1016/j.heliyon.2024.e38220.


Resveratrol attenuates non-steroidal anti-inflammatory drug-induced intestinal injury in rats in a high-altitude hypoxic environment by modulating the TLR4/NFκB/IκB pathway and gut microbiota composition.

Xue S, Shi W, Shi T, Tuerxuntayi A, Abulaiti P, Liu Z PLoS One. 2024; 19(8):e0305233.

PMID: 39133675 PMC: 11318858. DOI: 10.1371/journal.pone.0305233.


Alveolar hypoxia induces organ-specific inflammasome-related inflammation in male mouse lungs.

Udjus C, Halvorsen B, Kong X, Sagen E, Martinsen M, Yang K Physiol Rep. 2024; 12(14):e16143.

PMID: 39034131 PMC: 11260499. DOI: 10.14814/phy2.16143.


Meta-analysis identifying gut microbial biomarkers of Qinghai-Tibet Plateau populations and the functionality of microbiota-derived butyrate in high-altitude adaptation.

Zhao H, Sun L, Liu J, Shi B, Zhang Y, Qu-Zong C Gut Microbes. 2024; 16(1):2350151.

PMID: 38715346 PMC: 11086029. DOI: 10.1080/19490976.2024.2350151.


References
1.
Fullerton J, Gilroy D . Resolution of inflammation: a new therapeutic frontier. Nat Rev Drug Discov. 2016; 15(8):551-67. DOI: 10.1038/nrd.2016.39. View

2.
Neurath M . Cytokines in inflammatory bowel disease. Nat Rev Immunol. 2014; 14(5):329-42. DOI: 10.1038/nri3661. View

3.
Kerber E, Padberg C, Koll N, Schuetzhold V, Fandrey J, Winning S . The Importance of Hypoxia-Inducible Factors (HIF-1 and HIF-2) for the Pathophysiology of Inflammatory Bowel Disease. Int J Mol Sci. 2020; 21(22). PMC: 7697655. DOI: 10.3390/ijms21228551. View

4.
Coskun M, Salem M, Pedersen J, Nielsen O . Involvement of JAK/STAT signaling in the pathogenesis of inflammatory bowel disease. Pharmacol Res. 2013; 76:1-8. DOI: 10.1016/j.phrs.2013.06.007. View

5.
Cohen Katsenelson K, Stender J, Kawashima A, Lorden G, Uchiyama S, Nizet V . PHLPP1 counter-regulates STAT1-mediated inflammatory signaling. Elife. 2019; 8. PMC: 6692130. DOI: 10.7554/eLife.48609. View